ZoleRen

N/A

Report date: 2025/12/01 17:16:42
NME

Base Information

Drug NameZoleRen
Drug Alias Name188Re-zoledronic acid
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Rhenium > 188ReRadiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionFarnesyl diphosphate synthase inhibitorsBone resorption factor inhibitors
TargetsFarnesyl diphosphate synthaseBone resorption factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharm-Sintez
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharm-Sintez
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A